Gritstone Oncology Inc (GRTS) stock has fallen 6.71% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With GRTS Stock Today?
Gritstone Oncology Inc (GRTS) stock is down -0.28% while the S&P 500 has gained 0.42% as of 10:57 AM on Monday, May 3. GRTS is down -$0.03 from the previous closing price of $9.05 on volume of 121,565 shares. Over the past year the S&P 500 is higher by 47.70% while GRTS has gained 38.28%. GRTS lost -$2.79 per share in the over the last 12 months.
To screen for more stocks like Gritstone Oncology Inc click here.
More About Gritstone Oncology Inc
Gritstone Oncology Inc is a United States-based biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE-001 and SLATE-001.
Click Here to get the full Stock Score Report on Gritstone Oncology Inc (GRTS) Stock.